Partner
Thomas Axel Haag
Managing Partner, Linden Lake Ventures
- Firm
- Linden Lake Ventures
- Title
- Managing Partner
- Role
- Managing partner
- Known as
- Investor
Claim, correct or request removal
Record updated 4 October 2026
About
Thomas is Managing Partner of Linden Lake Venture Capital. He is a biotechnology investor, entrepreneur and intellectual property lawyer. Most recently he was CEO of Linden Lake portfolio company, AexeRNA Therapeutics, a next-generation mRNA lipid nanoparticle technology company he co-founded with the late Michael Buschmann of George Mason University and Drew Weissman at the University of Pennsylvania. AexeRNA was acquired by a large publicly traded biotechnology company.
Background
- Education
- He graduated from The George Washington University Law School. He earned a B.S. in Biology and Ph.D. in Molecular, Cell & Developmental Biology from UCLA where he was an NIH Pre-doctoral Fellow in Genetics.Source (opens in a new tab)
Is this you? Remove my profile
Loading relationship preview